-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*ST Gene issued a fixed increase plan on the evening of July 4th.
The company intends to non-publicly issue no more than 660,225,400 shares to no more than 10 specific objects at a price of no less than 6.
21 yuan per share, and the total amount of raised funds will not exceed 4.
1 billion yuan.
It is used to invest in new materials and new energy projects and repay part of bank loans, aiming to realize the transformation of the company's main business
.
Upon application, the company's shares will resume trading on July 5
.
According to the plan, the non-publicly issued shares of the company subscribed by the issuance target shall not be transferred within 12 months from the date of listing of the newly added shares
.
At the same time, after the issuance is completed by the participating company’s non-public issuance and its actual controllers, the number of voting rights in the issuer’s shares directly and indirectly held shall not exceed the number of voting rights in the company’s shares controlled by Haorong Group
.
For this reason, this non-public offering will not lead to changes in the company's controlling shareholders and actual controllers
.
According to the plan, the company plans to invest 491 million yuan of raised funds for the "Carbonyl Metal Functional Material Construction Project (Phase I)" project
.
The total investment of the project is 525 million yuan.
After reaching the capacity, it will achieve an annual output of 10,000 tons of carbonyl iron powder.
The latter can be widely used in metallurgy, electronics, military industry, machinery, medicine, chemical and food and other fields
.
According to calculations, the annual sales income of the project is 385 million yuan after the project is put into production, the annual net profit is 95.
41 million yuan, and the after-tax financial internal rate of return is 23.
87%
.
In addition, the "R&D and production base construction project for lithium battery cathode materials with an annual output of 20,000 tons" plans to invest 1.
266 billion yuan in raised funds, and the total investment of the project is estimated to be 1.
494 billion yuan
.
The listed company intends to invest the raised funds into Yarong Technology in the form of subscribing for no more than 703,194,400 ordinary shares issued by Yarong Technology, a company listed on the NEEQ for 1.
80 yuan per share, and Yarong Technology will implement the project through the establishment of a new subsidiary
.
The project will achieve an annual output of 20,000 tons of lithium nickel cobalt manganese oxide, 1,310 tons of copper sulfate, and 770 tons of zinc sulfate.
After reaching the capacity, the annual sales income is expected to be 2.
732 billion yuan, the annual net profit is 254 million yuan, and the after-tax financial internal rate of return of the project is 21.
77 %
.
The "20,000-ton battery-grade lithium carbonate project with an annual output of 20,000 tons" intends to invest 1.
077 billion yuan to raise funds, which will be implemented by the grandson company 9554661 Canada Inc.
of Gene International, which will acquire Quebec Lithium Inc.
lithium mining and battery-grade carbonic acid.
The lithium production line is upgraded to form an annual production capacity of 20,000 tons of 99.
5% battery-grade lithium carbonate.
The estimated annual sales revenue is 326 million Canadian dollars, the average annual net profit is 142 million Canadian dollars, and the financial internal rate of return is 67.
19%
.
In addition, after the non-public issuance of shares, the company plans to use part of the raised funds of 1.
2 billion yuan to repay loans from banks and other institutions to optimize the company’s capital structure, meet the company’s capital needs for future business development, reduce financial expenses, and increase the company’s The level of profitability
.
*ST Gene said that through this issuance, the company can realize the transformation and upgrading of its main business.
Under the condition that the original main business remains unchanged, it has added new materials and new energy fields, and the company's future new materials and new Energy-related income will increase substantially
.
Through this non-public issuance, the company's asset scale and capital strength will increase substantially, risk resistance and sustained profitability will be further enhanced, and the overall core competitiveness will be further improved
.
The company intends to non-publicly issue no more than 660,225,400 shares to no more than 10 specific objects at a price of no less than 6.
21 yuan per share, and the total amount of raised funds will not exceed 4.
1 billion yuan.
It is used to invest in new materials and new energy projects and repay part of bank loans, aiming to realize the transformation of the company's main business
.
Upon application, the company's shares will resume trading on July 5
.
According to the plan, the non-publicly issued shares of the company subscribed by the issuance target shall not be transferred within 12 months from the date of listing of the newly added shares
.
At the same time, after the issuance is completed by the participating company’s non-public issuance and its actual controllers, the number of voting rights in the issuer’s shares directly and indirectly held shall not exceed the number of voting rights in the company’s shares controlled by Haorong Group
.
For this reason, this non-public offering will not lead to changes in the company's controlling shareholders and actual controllers
.
According to the plan, the company plans to invest 491 million yuan of raised funds for the "Carbonyl Metal Functional Material Construction Project (Phase I)" project
.
The total investment of the project is 525 million yuan.
After reaching the capacity, it will achieve an annual output of 10,000 tons of carbonyl iron powder.
The latter can be widely used in metallurgy, electronics, military industry, machinery, medicine, chemical and food and other fields
.
According to calculations, the annual sales income of the project is 385 million yuan after the project is put into production, the annual net profit is 95.
41 million yuan, and the after-tax financial internal rate of return is 23.
87%
.
In addition, the "R&D and production base construction project for lithium battery cathode materials with an annual output of 20,000 tons" plans to invest 1.
266 billion yuan in raised funds, and the total investment of the project is estimated to be 1.
494 billion yuan
.
The listed company intends to invest the raised funds into Yarong Technology in the form of subscribing for no more than 703,194,400 ordinary shares issued by Yarong Technology, a company listed on the NEEQ for 1.
80 yuan per share, and Yarong Technology will implement the project through the establishment of a new subsidiary
.
The project will achieve an annual output of 20,000 tons of lithium nickel cobalt manganese oxide, 1,310 tons of copper sulfate, and 770 tons of zinc sulfate.
After reaching the capacity, the annual sales income is expected to be 2.
732 billion yuan, the annual net profit is 254 million yuan, and the after-tax financial internal rate of return of the project is 21.
77 %
.
The "20,000-ton battery-grade lithium carbonate project with an annual output of 20,000 tons" intends to invest 1.
077 billion yuan to raise funds, which will be implemented by the grandson company 9554661 Canada Inc.
of Gene International, which will acquire Quebec Lithium Inc.
lithium mining and battery-grade carbonic acid.
The lithium production line is upgraded to form an annual production capacity of 20,000 tons of 99.
5% battery-grade lithium carbonate.
The estimated annual sales revenue is 326 million Canadian dollars, the average annual net profit is 142 million Canadian dollars, and the financial internal rate of return is 67.
19%
.
In addition, after the non-public issuance of shares, the company plans to use part of the raised funds of 1.
2 billion yuan to repay loans from banks and other institutions to optimize the company’s capital structure, meet the company’s capital needs for future business development, reduce financial expenses, and increase the company’s The level of profitability
.
*ST Gene said that through this issuance, the company can realize the transformation and upgrading of its main business.
Under the condition that the original main business remains unchanged, it has added new materials and new energy fields, and the company's future new materials and new Energy-related income will increase substantially
.
Through this non-public issuance, the company's asset scale and capital strength will increase substantially, risk resistance and sustained profitability will be further enhanced, and the overall core competitiveness will be further improved
.
